Tower Research Capital LLC (Trc) Aprea Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

Shares

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 10, 2023	BUY	$0.32 - $15.2 $8,086 - $384,104	25,270 Added 113.23%	47,588 $15,000
Q3 2022 Nov 10, 2022	SELL	$0.71 - $13.6 $17,781 - $340,598	-25,044 Reduced 52.88%	22,318 $15,000
Q2 2022 Aug 15, 2022	BUY	$0.62 - $1.94 $8,637 - $27,026	13,931 Added 41.67%	47,362 $36,000
Q1 2022 May 12, 2022	BUY	$1.59 - $3.16 $18,133 - $36,039	11,405 Added 51.78%	33,431 $62,000
Q4 2021 Feb 14, 2022	BUY	$2.87 - $5.58 $52,902 - $102,856	18,433 Added 513.03%	22,026 $64,000
Q3 2021 Nov 15, 2021	SELL	$3.43 - $5.63 $9,874 - $16,208	-2,879 Reduced 44.48%	3,593 $18,000
Q2 2021 Aug 16, 2021	SELL	$4.05 - $5.5 $14,515 - $19,712	-3,584 Reduced 35.64%	6,472 $31,000
Q1 2021 May 17, 2021	BUY	$4.73 - $8.15 $30,276 - $52,168	6,401 Added 175.13%	10,056 $51,000
Q4 2020 Feb 16, 2021	SELL	$4.92 - $30.67 $24,663 - $153,748	-5,013 Reduced 57.83%	3,655 $18,000
Q3 2020 Nov 16, 2020	BUY	$21.66 - $38.86 $156,298 - $280,413	7,216 Added 496.97%	8,668 $208,000
Q2 2020 Aug 13, 2020	BUY	$25.47 - $39.69 $36,982 - $57,629	1,452 New	1,452 $56,000

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$2,741
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.